{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MEHTSOP063 Commercial Research Z Accounts 2.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "COMMERCIAL RESEARCH Z ACCOUNTS"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MEHTSOP063"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP)"
                    },
                    {
                        "text": "SOP"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All Staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "th9 January 2020"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "th8 January 2023"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "Service Development"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "17"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Corporate"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Tracey Camburn, R&D Director"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\uf0fcMEHT \u25a1 BTUH \u25a1 SUH"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "R&D and Finance Group"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "24/12/2019"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Lauren Perkins"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "02/01/2020"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "DRAG Chair's Action"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "9th January 2020"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group"
                    },
                    {
                        "text": "Date: January 2020"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "Trust Intranet/ Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MEHTSOP063 Commercial Research Z Accounts 2.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 4,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With:"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Kevin Beaton"
                    },
                    {
                        "text": "Medical Director"
                    },
                    {
                        "text": "24/12/2019"
                    },
                    {
                        "text": "Stephen Beeson"
                    },
                    {
                        "text": "Director of Finance"
                    },
                    {
                        "text": "12/12/2019"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 1,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) Research and Development Operational Policy \u2013 04052"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 6,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Tracey Camburn"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "June 2015"
                    },
                    {
                        "text": "2.0"
                    },
                    {
                        "text": "Tracey Camburn"
                    },
                    {
                        "text": "Updated from previous SOP due to finance department changes for the allocation of Commercial Research Funds"
                    },
                    {
                        "text": "9th January 2020"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 7,
            "data": {
                "is_heading": 1,
                "text": "Contents"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 8,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................. 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 9,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 10,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions ................................................................................................................... 4"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 11,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities ........................................................................................ 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 12,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Procedure .................................................................................................................... 5"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 13,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Monitoring and Audit .................................................................................................. 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 14,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "References .................................................................................................................. 6"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 15,
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Equality Impact Assessment ..................................................................................... 7 Appendix 1: R&D form to be completed for expenditure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 16,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Process for applying for Consultant Research Z account funds"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 17,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 18,
            "data": {
                "is_heading": 0,
                "text": "Commercial Research Z Accounts / MEHTSOP063/2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 19,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 20,
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 21,
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "The  purpose  is  to  define  the  requirement  for  use  of  commercial  research  Z accounts for the purpose of commercial research projects within MSE."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 22,
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "This document updates the previous SOP and processes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 23,
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 24,
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This SOP applies to any researcher who undertakes a commercial research project across MEHT."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 25,
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "Where a commercial research project is undertaken at MEHT any income due under the terms of the commercial contract must be paid into a designated Z account for each research project."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 26,
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "Each project will be provided with a designated commercial research Z account by finance at the time the study is set up at MEHT and as requested by R&D."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 27,
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "These  funds  will  be  allocated  as  per  the  agreed  National  Institute  for  Health Research (NIHR) approved commercial study costing template, as evidenced within a NHR approved Clinical Trial Agreement (CTA)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 28,
            "data": {
                "is_heading": 0,
                "prefix": 2.5,
                "text": "Funds will be used to cover research costs incurred by the trust for all staff time spent working on the project for the duration of the project and includes any service support costs, e.g. Radiology, pharmacy, lab costs."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 29,
            "data": {
                "is_heading": 0,
                "prefix": 2.6,
                "text": "There will be only one shared Consultants Research Z account which will be set up for all commercial research income. Payments will be transferred to this account from the commercial project specific Z account in line with the costing template, as confirmed by R&D and Finance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 30,
            "data": {
                "is_heading": 0,
                "prefix": 2.7,
                "text": "All research active PI consultants will have the opportunity to use the funds in the Consultants Research Z account, please see section 5.2 for what the money can be used for."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 31,
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            }
        },
        {
            "type": "table",
            "sequence_num": 32,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "CTA"
                    },
                    {
                        "text": "Clinical Trial Agreement"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South Essex University Hospitals Group"
                    },
                    {
                        "text": "MEHT"
                    },
                    {
                        "text": "Mid Essex Hospital Services NHS Trust"
                    },
                    {
                        "text": "NIHR"
                    },
                    {
                        "text": "National Institute for Health Research"
                    },
                    {
                        "text": "PI"
                    },
                    {
                        "text": "Principal Investigator"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": "Research and Development"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 33,
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Roles and Responsibilities"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 34,
            "data": {
                "is_heading": 0,
                "prefix": 4.1,
                "text": "Commercial Research Z accounts will be approved and monitored by the R&D Director and Finance Director/Lead."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 35,
            "data": {
                "is_heading": 0,
                "prefix": 4.2,
                "text": "All staff must adhere to the Trust's mandatory training programme and Training Needs analysis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 36,
            "data": {
                "is_heading": 0,
                "prefix": 4.3,
                "text": "Roles"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 37,
            "data": {
                "is_heading": 0,
                "text": "R&D team review and confirm costing template, issue capacity and capability of commercial research within MEHT, request new Z accounts for commercial research projects and invoice and allocate commercial research monies as required."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 38,
            "data": {
                "is_heading": 0,
                "text": "Finance department will review and confirm the Z account details and monitor income and expenditure in the accounts."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 39,
            "data": {
                "is_heading": 0,
                "text": "R&D Director or R&D Manager will review, authorise and confirm appropriate expenditure of Z account monies."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 40,
            "data": {
                "is_heading": 0,
                "text": "Finance Director will issue final approval of any expenditure."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 41,
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Procedures"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 42,
            "data": {
                "is_heading": 1,
                "prefix": 5.1,
                "text": "Allocation of funds"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 43,
            "data": {
                "is_heading": 0,
                "text": "5.1.1 Funds received for commercial research will be allocated as per the NIHR costing template. This will be reviewed and agreed in advance of the project starting at MEHT. Funds will flow through the project specific Z account."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 44,
            "data": {
                "is_heading": 0,
                "text": "5.1.2 Research project income allocated to the PI under the NIHR costing template will be invoiced as and when appropriate by R&D and allocated to the Consultants Research Z account by finance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 45,
            "data": {
                "is_heading": 0,
                "text": "5.1.3 This account will be managed by R&D and finance and used as per the guidance within this SOP."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 46,
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "5.1.4 Any Consultants Research Money Z account funds can be spent in accordance with this SOP once approved by R&D and Finance (please see section  and Appendix 2)."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 47,
            "data": {
                "is_heading": 0,
                "text": "5.1.5 The research money received into the Consultants Research Money Z account will be reviewed annually by finance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 48,
            "data": {
                "is_heading": 1,
                "prefix": 5.2,
                "text": "Application to spend funds"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 49,
            "data": {
                "is_heading": 0,
                "text": "5.2.1 Consultants Research Z account money received by virtue of a Commercial Research project can be used for research purposes only. This can include but is not limited to:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 50,
            "data": {
                "is_heading": 0,
                "text": "Travel to conferences, in accordance with NHS employers guidelines and trust policies,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 51,
            "data": {
                "is_heading": 0,
                "text": "Attendance at conferences/ meetings to present scientific posters,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 52,
            "data": {
                "is_heading": 0,
                "text": "Publication of articles registered with audit or R&D,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 53,
            "data": {
                "is_heading": 0,
                "text": "Appropriate equipment for departments to enhance and develop research,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 54,
            "data": {
                "is_heading": 0,
                "text": "Training and development for consultant or a member of their team - to be applied for and approved through medical/nursing educational training,"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 55,
            "data": {
                "is_heading": 0,
                "text": "Funding of research staff \u2013 this must be approved in advance, please speak to R&D."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 56,
            "data": {
                "is_heading": 0,
                "text": "5.2.2 Requests for expenditure will be applied for via R&D and reviewed by both R&D and Finance for appropriateness. No funds can be spent from these accounts without prior written approval from both departments."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 57,
            "data": {
                "is_heading": 0,
                "text": "5.2.3 R&D and finance have the right to refuse any expenditure requests which are deemed to be inappropriate, e.g. first class travel; items not competitively priced etc"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 58,
            "data": {
                "is_heading": 0,
                "text": "5.2.4 Once expenditure is approved payments will be made in the following ways (please also see Appendix 2):"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 59,
            "data": {
                "is_heading": 0,
                "text": "5.2.5 If the approved expense is paid for directly by a member of MEHT staff, appropriate paperwork must be submitted via the SEL Expense system using the expense code which will be provided within the approval."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 60,
            "data": {
                "is_heading": 0,
                "text": "5.2.6 If the approved expense is being made via procurement, requests are to be made via the INTEGRA 2 system. The Non Stock Requisition Book is no longer approved for use. All supporting documentation must be included with the request."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 61,
            "data": {
                "is_heading": 0,
                "text": "5.2.7 At the start of every financial year, R&D will notify all research active PI's of the money available to be spent from the Consultants Research Money Z account."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 62,
            "data": {
                "is_heading": 0,
                "text": "5.2.8 All research active PI's can apply to spend money from the Consultants Research Money Z account at any time of the year."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 63,
            "data": {
                "is_heading": 0,
                "text": "5.2.9 R&D will remind all research active PI's of any money that hasn't been spent in January, to encourage expenditure of funds before the end of the financial year."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 64,
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Monitoring and Audit"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 65,
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Finance will review the Z accounts on an annual basis."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 66,
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "If research money is not spent within two years of transfer into the Z accounts, the Trust has the right to use this money for other Trust purposes."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 67,
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "Breaches of this policy will be reported via the DatixWeb system, where  upon trends can be identified and brought to the attention of the management and clinical Stakeholders. This will include failure/breakdown of equipment impairing service delivery, management of staff sickness and resultant treatment capacity deficits."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 68,
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "Patient Safety & Quality Committee will be supplied with DatixWeb trend data, and any incidents requiring immediate assessment will be fed back directly."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 69,
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Equality Impact Assessment"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 70,
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "Mid Essex Hospital Services NHS Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals. (Refer to Appendix 3)"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 71,
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: R&D form to be completed for expenditure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 72,
            "data": {
                "is_heading": 1,
                "text": "Research Expenditure"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 73,
            "data": {
                "is_heading": 1,
                "text": "Budget Code:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 74,
            "data": {
                "is_heading": 1,
                "text": "Note: Expenditure of research account monies must be used to facilitate the support of non- commercially funded research activity i.e. equipment for research study, attendance at training sessions relating to research etc."
            }
        },
        {
            "type": "table",
            "sequence_num": 75,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Please describe how you intend to spend the money from the consultant"
                    },
                    {
                        "text": "commercial research account."
                    },
                    {
                        "text": "On what"
                    },
                    {
                        "text": "How much"
                    },
                    {
                        "text": "By When"
                    },
                    {
                        "text": "Consumables: Academic Development"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 76,
            "data": {
                "is_heading": 1,
                "text": "Signed:\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Requesting Consultant"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 77,
            "data": {
                "is_heading": 1,
                "text": "Signed: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Finance Department"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 78,
            "data": {
                "is_heading": 1,
                "text": "Approved: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 R& D Director:  Date:"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 79,
            "data": {
                "is_heading": 0,
                "text": "Please return this form to Mandy Austin, R&D Coordinator & Governance Facilitator, R&D Office, C254, West Wing or email to mandy.austin@meht.nhs.uk"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 80,
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Process for applying for Consultant Research Z account funds"
            }
        },
        {
            "type": "image",
            "sequence_num": 81,
            "data": {
                "url": "MEHTSOP063 Commercial Research Z Accounts 2.0.003.png"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 82,
            "data": {
                "is_heading": 1,
                "text": "Check with R&D funds available in the appropriate account"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 83,
            "data": {
                "is_heading": 1,
                "text": "Check with R&D that the purchase falls within the criteria for account expenditure. An email confirmation will be provided if approved."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 84,
            "data": {
                "is_heading": 1,
                "text": "Complete  the  Research  Expenditure  Form (Appendix 1) and return to R&D along with all supporting documentation. This must be countersigned by R&D Director and Finance."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 85,
            "data": {
                "is_heading": 1,
                "text": "Once approved, an email confirmation will be issued."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 86,
            "data": {
                "is_heading": 1,
                "text": "Request the approved expense via the INTEGRA 2 system. A cost code will be provided once expense approved. If the item is paid for by the staff member please use the SEL EXPENSE system using the cost code provided. In both instances please attach ALL supporting documentation."
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 87,
            "data": {
                "is_heading": 0,
                "text": "Commercial Research Z Accounts / MEHTSOP063/2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 88,
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 89,
            "data": {
                "is_heading": 0,
                "text": "Commercial Research Z Accounts / MEHTSOP063/2.0"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 90,
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Preliminary Equality Analysis"
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 91,
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Commercial Research Z Accounts / MEHTSOP063"
            }
        },
        {
            "type": "table",
            "sequence_num": 92,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "A change in a service to patients"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A change to an existing policy"
                    },
                    {
                        "text": "X"
                    },
                    {
                        "text": "A change to the way staff work"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "A new policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Full review"
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "Updated from previous SOP due to finance department changes for the allocation of Commercial Research Funds"
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Trust clinical departments due to appropriate allocation of commercial funds and PI consultants."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change? b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 and 2"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 93,
            "data": {
                "is_heading": 1,
                "text": "Preliminary analysis completed by:"
            }
        },
        {
            "type": "table",
            "sequence_num": 94,
            "data": {
                "num_rows": 1,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Tracey Camburn"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Research & Development Director"
                    },
                    {
                        "text": "Date"
                    },
                    {
                        "text": "November 2019"
                    }
                ]
            }
        },
        {
            "type": "ListItem",
            "sequence_num": 95,
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Page  of"
            }
        }
    ]
}